NANTES, France--(BUSINESS WIRE)--Regulatory News: OSE Immunotherapeutics SA (ISIN: FR0012127173; Mnemo: OSE) today announced that the United States Patent and Trademark Office has granted a new patent ...
Nantes, France, December 9, 2025 - 7:30am CET - OSE Immunotherapeutics SA (ISIN: FR0012127173; Mnemo: OSE), today announced its new three-year strategic plan designed to accelerate development of its ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback